Centrica plc has announced that two of its executive directors, Christopher O'Shea and Russell O'Brien, have acquired Centrica ordinary shares under the company's Share Incentive Plan. The transactions were made on behalf of the directors by Equiniti Share Plan Trustees Limited. The details of the transactions are as follows:
- Christopher O'Shea acquired 99 partnership shares and 22 matching shares at a price of £1.5207 per share for a total transaction value of £183.63.
- Russell O'Brien also acquired 99 partnership shares and 22 matching shares at the same price of £1.5207 per share for a total transaction value of £183.63.
The transactions took place on November 10, 2023, with the partnership shares being acquired on the London Stock Exchange and the matching shares being acquired outside a trading venue.
Centrica plc is listed on the London Stock Exchange and its registered office is located in Windsor, Berkshire. The company's legal entity identifier number is E26EDV109X6EEPBKVH76.